Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial…
Strong execution across all product lines led to gross margin improvement by 44% BANGALORE, India, Oct. 23, 2025 /PRNewswire/ --…
Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to significantly improve overall survival versus chemotherapy in this…
Collaboration with Schools and Communities to Protect Children and Vulnerable Road Users In the compact and dynamic city-state of most…
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR®…
MUMBAI, India, Aug. 27, 2025 /PRNewswire/ -- Urban Company Limited today announced the launch of Revamp, a new sub-brand, to redefine…
Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an…
Press release Ecully, July 30, 2025 – 7 p.m. SPINEWAY H1 2025 results Continued improvement in results and financial positionFull-year…
Campaign film link: https://www.instagram.com/reel/DLrGKtyosho/?igsh=bDVibnN3MWgzYmc= MUMBAI, India, July 4, 2025 /PRNewswire/ -- MR.DIY, Asia's largest home improvement and lifestyle retail chain,…
Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved 75% or greater improvement in overall…